IOL Chemicals and Pharmaceuticals Limited

₹ 619.5

resentation Q4 & FY26 Q4 & FY26 Performance Q4 & FY26 Standalone Performance Highlights Q4 FY26 ₹ 619.5 Cr Revenue from Operations 17.4% YoY FY26 ₹ 2,319.1 Cr Revenue from Operations 11.5% YoY ₹ 94.3

17.4%

formance Q4 & FY26 Standalone Performance Highlights Q4 FY26 ₹ 619.5 Cr Revenue from Operations 17.4% YoY FY26 ₹ 2,319.1 Cr Revenue from Operations 11.5% YoY ₹ 94.3 Cr EBITDA 39.8% YoY EBITDA Mar

₹ 2,319.1

26 Standalone Performance Highlights Q4 FY26 ₹ 619.5 Cr Revenue from Operations 17.4% YoY FY26 ₹ 2,319.1 Cr Revenue from Operations 11.5% YoY ₹ 94.3 Cr EBITDA 39.8% YoY EBITDA Margin 15.2% ₹ 290.4 Cr

11.5%

Q4 FY26 ₹ 619.5 Cr Revenue from Operations 17.4% YoY FY26 ₹ 2,319.1 Cr Revenue from Operations 11.5% YoY ₹ 94.3 Cr EBITDA 39.8% YoY EBITDA Margin 15.2% ₹ 290.4 Cr EBITDA 29.3% YoY EBITDA Margin

₹ 94.3

619.5 Cr Revenue from Operations 17.4% YoY FY26 ₹ 2,319.1 Cr Revenue from Operations 11.5% YoY ₹ 94.3 Cr EBITDA 39.8% YoY EBITDA Margin 15.2% ₹ 290.4 Cr EBITDA 29.3% YoY EBITDA Margin 12.4% ₹ 53.2

39.8%

rom Operations 17.4% YoY FY26 ₹ 2,319.1 Cr Revenue from Operations 11.5% YoY ₹ 94.3 Cr EBITDA 39.8% YoY EBITDA Margin 15.2% ₹ 290.4 Cr EBITDA 29.3% YoY EBITDA Margin 12.4% ₹ 53.2 Cr PAT 68.2% Y

15.2%

FY26 ₹ 2,319.1 Cr Revenue from Operations 11.5% YoY ₹ 94.3 Cr EBITDA 39.8% YoY EBITDA Margin 15.2% ₹ 290.4 Cr EBITDA 29.3% YoY EBITDA Margin 12.4% ₹ 53.2 Cr PAT 68.2% YoY PAT Margin 8.6% ₹ 13

₹ 290.4

₹ 2,319.1 Cr Revenue from Operations 11.5% YoY ₹ 94.3 Cr EBITDA 39.8% YoY EBITDA Margin 15.2% ₹ 290.4 Cr EBITDA 29.3% YoY EBITDA Margin 12.4% ₹ 53.2 Cr PAT 68.2% YoY PAT Margin 8.6% ₹ 137.7 Cr PAT

29.3%

ue from Operations 11.5% YoY ₹ 94.3 Cr EBITDA 39.8% YoY EBITDA Margin 15.2% ₹ 290.4 Cr EBITDA 29.3% YoY EBITDA Margin 12.4% ₹ 53.2 Cr PAT 68.2% YoY PAT Margin 8.6% ₹ 137.7 Cr PAT 36.4% YoY PAT

12.4%

YoY ₹ 94.3 Cr EBITDA 39.8% YoY EBITDA Margin 15.2% ₹ 290.4 Cr EBITDA 29.3% YoY EBITDA Margin 12.4% ₹ 53.2 Cr PAT 68.2% YoY PAT Margin 8.6% ₹ 137.7 Cr PAT 36.4% YoY PAT Margin 5.9% 3 Q4 & FY2

₹ 53.2

94.3 Cr EBITDA 39.8% YoY EBITDA Margin 15.2% ₹ 290.4 Cr EBITDA 29.3% YoY EBITDA Margin 12.4% ₹ 53.2 Cr PAT 68.2% YoY PAT Margin 8.6% ₹ 137.7 Cr PAT 36.4% YoY PAT Margin 5.9% 3 Q4 & FY26 Standal

68.2%

39.8% YoY EBITDA Margin 15.2% ₹ 290.4 Cr EBITDA 29.3% YoY EBITDA Margin 12.4% ₹ 53.2 Cr PAT 68.2% YoY PAT Margin 8.6% ₹ 137.7 Cr PAT 36.4% YoY PAT Margin 5.9% 3 Q4 & FY26 Standalone Performan

“Asia-Pacific—led by India and China posts the fastest growth at 8.7% CAGR.”

Existing Facility

1

COMPANY

1

INVESTOR RELATIONS ADVISORS

1

Existing Facility

Spanning 180+ acres Expansion: Purchased 101 acres on Chandigarh-Bathinda Highway for new site development Zero Discharge Effluent Treatment Plant Recognized with EcoVadis Silver Medal- Ranks among Top 15% companies globally. Debt to Equity Ratio 0.08 10 Segment Overview- Pharmaceuticals Largest global producer of Ibuprofen with complete backward integration, having an annual capacity of 12,000 MT Expanding non-Ibuprofen API segment with a diversified portfolio across multiple therapeutic areas, strengthening growth beyond Ibuprofen A fully backward-integrated and automated facility for manufacturing paracetamol, with an annual capacity of 10,800 MT 14 DMFs with USFDA 21 CEPs with EDQM The state-of-the-art facility comprises 11 dedicated units focused on efficient, high-quality production across a diversified product range Existing Product Portfolio Application across therapeutic areas Strategic Shift Towards High-Value APIs Ibuprofen Ibuprofen Lysinate Ibuprofen Sodium Dex-Ibuprofen M

COMPANY

IOL Chemicals and Pharmaceuticals Ltd. CIN : L24116PB1986PLC007030 Mr. Abhay Raj Singh - Sr. VP & Company Secretary E-mail: investor@iolcp.com www.iolcp.com investor@iolcp.com www.iolcp.com

INVESTOR RELATIONS ADVISORS

MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services prachi.ambre@in.mpms.mufg.com prachi.ambre@in.mpms.mufg.com Ms. Prachi Ambre prachi.ambre@in.mpms.mufg.com irfan.raeen@in.mpms.mufg.com irfan.raeen@in.mpms.mufg.com Mr. Irfan Raeen irfan.raeen@in.mpms.mufg.com Meeting Request Link Link Website: https://in.mpms.mufg.com/ Thank You